The latest at MBC Biolabs
The latest at MBC Biolabs
With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseases
CAGE Bio Inc. today announced a research and development agreement with Nitto Denko Corporation for a transdermal formulation of undisclosed molecules.
Biotech startup announces R&D collaboration with major Japanese drug delivery company
CAGE Bio Inc. today announced a research and development agreement with Nitto Denko Corporation for a transdermal formulation of undisclosed molecules.
BioWorld: Drug developers’ Golden Ticket
BioWorld: Drug developers’ Golden Ticket, worth a lot more than a tour of a candy manufacturing plant
Nitrome Biosciences Raises $38M Series A Financing
Read online article at BUSINESS WIRE San Francisco, Calif., April 21, 2020 /BUSINESS WIRE -- N [...]
CellFE Raises $3.6M in Seed Round
Read online article at YAHOO finance SAN CARLOS, Calif., Jan. 16, 2020 /PRNewswire/ -- CellFE, [...]
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics
And Its Tech Is Already Being Used Against Coronavirus Mammoth Biosciences is a MBC BioLabs [...]
The 2020 AbbVie Golden Ticket
Apply for the Golden Ticket until February 10, 2020.
How a biotech incubator is helping Big Pharma punch ‘golden tickets’ for startups
By Ron Leuty – Staff Reporter, San Francisco Business Times Dec 9, 2019, 2:16pm PST Read [...]
LogicInk appears on “The World According to Jeff Goldblum”, new series on Disney+
MBC BioLabs resident company, LogicInk, appeared on the Disney+ streaming platform, as par [...]
Astellas and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until October 11, 2019.
Celgene and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until August 16, 2019.
Co-founder and CEO of Mammoth Biosciences on Fortune’s 2019 40 Under 40
Trevor Martin Courtesy of Molly Jorgensen - Mammoth Biosciences Mammoth Biosciences came t [...]
An early taste of Wild Type Salmon
Wild Type’s lab-grown salmon product. Source: Wild Type Inc. Read original article by Lyd [...]
Announcing Winners of the 2019 AMGEN Golden Ticket
Regencor and Nitrome Biosciences have each been awarded an Amgen Golden Ticket to MBC BioLabs
Announcing Winner of the 2019 Servier Golden Ticket
The 2019 Servier Golden Ticket at MBC BioLabs has been awarded to Quartz Therapeutics.
Apply for the 2019 AMGEN Golden Ticket by 5/3/2019!
AMGEN and MBC BioLabs invite you to apply for the 2019 AMGEN Golden Ticket!
MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over five year [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and [...]
Announcing Recipients of the Golden Ticket Program
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign partnersh [...]
Mammoth Biosciences Featured on Forbes 30 Under 30
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, CEO of [...]
Golden Ticket Offered
MBC BioLabs, the premier Bay Area life-science incubator, will present its Golden Ticket programs this year as well as future initiatives at MBC BioLabs through a sponsorship from Celgene.
Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine
After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took 2 benc [...]